Overexpression of proenkephalin in the amygdala potentiates the anxiolytic effects of benzodiazepines

Neuropsychopharmacology

Volumn 22, Issue 1, 2000, Pages 77-88

  Kang, Wen ^a   Wilson, Steven P ^a   Wilson, Marlene A ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Amygdala; Anxiety; Benzodiazepines; Gene transfer; Herpes virus vectors; Opioid peptides

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIAZEPAM; MORPHINE; NALOXONE; OPIATE PEPTIDE; PROENKEPHALIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; DRUG ACTIVITY; GENE OVEREXPRESSION; GENE TRANSFER; HERPES VIRUS; INTRAPERITONEAL DRUG ADMINISTRATION; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; VIRUS INFECTION; VIRUS REPLICATION;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; BETA-GALACTOSIDASE; DEFECTIVE VIRUSES; DIAZEPAM; DNA, COMPLEMENTARY; ENKEPHALINS; GENE TRANSFER TECHNIQUES; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; MAZE LEARNING; NALOXONE; PROTEIN PRECURSORS; RATS; RATS, LONG-EVANS; RNA, MESSENGER;

EID: 0033990768     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00090-1     Document Type: Article

References (53)

1. Agmo A., Galvan A., Heredia A., Morales M. Naloxone blocks the antianxiety but not the motor effects of benzodiazepines and pentobarbital. Experimental studies and literature review Psychopharmacology. 120:1995;186-194.
2. Belzung C., Agmo A. Naloxone potentiates the effects of subeffective doses of anxiolytic agents in mice. Eur J Pharmacol. 323:1997;133-136.
3. Billingsley M.L., Kubena R.K. The effects of naloxone and picrotoxin on the sedative and anticonflict effects of benzodiazepines. Life Sci. 22:1978;897-906.
4. Britton D.R., Britton K.T., Dalton D., Vale W. Effects of naloxone on anti-conflict and hyperphagic actions of diazepam. Life Sci. 29:1981;1297-1302.
5. Carlezon W.A. Jr., Broundy V.A., Haile C.N., Lane S.B., Kalb R.G., Neve R.L., Nester E.J. Sensitization to morphine induced by viral-mediated gene transfer. Science. 277:1997;812-814.
6. Cooper S.J. Benzodiazepine-opiate antagonist interactions in relation to feeding and drinking behavior. Life Sci. 32:1983;1043-1051.
7. Darke S., Swift W., Hall W., Ross M. Drug use, HIV risk-taking and psychosocial correlates of benzodiazepines use among methadone maintenance clients. Drug Alcohol Depend. 34:1993;67-70.
8. Davis M., Walker D.L., Lee Y. Amygdala and bed nucleus of the stria terminalis - differential roles in fear and anxiety measured with the acoustic startle reflex. Phil. Trans. Royal Soc. London - Series B: Biol Sci. 352:1997;1675-1687.
9. Davis M., Rainnie D., Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. TINS. 17:1994;208-214.
10. Dobson A.T., Margolis T.P., Sedarati F., Stevens J.G., Feldman L.T. A latent, nonpathogenic HSV-1-derived vector stably expresses β-galactosidase in mouse neurons. Neuron. 5:1990;353-360.
11. Duka T., Cumin R., Haefely W., Herz A. Naloxone blocks the effect of diazepam and meprobamate on conflict behaviour in rats. Pharm Biochem Behav. 15:1981;115-117.
12. Duka T., Wuster M., Herz A. Rapid changes in enkephalin levels in rat striatum and hypothalamus induced by diazepam. Naunyn Schmiedebergs Arch Pharmacol. 309:1979;1-5.
13. Duka T., Millan M.J., Ulsamer B., Doenicke A. Naloxone attenuates the anxiolytic action of diazepam in man. Life Sci. 31:1982;1833-1836.
14. File S.E., Rodgers R.J. Partial anxiolytic action of morphine sulphate following microinjection into the central nucleus of the amygdala in rats. Pharm Biochem Behav. 11:1979;313-318.
15. File S.E., Zangrossi H., Viana M., Graeff F.G. Trial 2 in the elevated plus-maze. A different form of fear Psychopharmacology. 111:1993;491-494.
16. Glorioso J.C., DeLuca N.A., Fink D.J. Development and application of herpes simplex virus vectors for human gene therapy. Ann Rev Microbiol. 49:1995;675-710.
17. Gonzalez L.E., Andrews N., File S.E. 5-HT1a and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Res. 732:1996;145-153.
18. Good A.J., Westbrook R.F. Effects of a microinjection of morphine into the amygdala on the acquisition and expression of conditioned fear and hypoalgesia in rats. Behav Neurosci. 109:1995;631-641.
19. Griebel G., Sanger D.J., Perrault G. The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands. Psychopharmacology. 124:1996;245-254.
20. A-benzodiazepine receptor complex and anxiety. Sartorius N., Andreoli V., Cassano G., Eisenberg L., Kielholz P., Pancheri P., Racagni G. Anxiety. Psychobiological and Clinical Perspectives. 1990;23-36 Hemisphere Publishing Corporation, New York.
21. Honkaniemi J., Pelto-Huikko M., Rechardt L., Isola J., Lammi A., Fuxe K., Gustafsson J.A., Wikstrom A.-C., Hokfelt T. Colocalization of peptide and glucocorticoid receptor immunoreativities in rat central amygdaloid nucleus. Neuroendocrinology. 55:1992;451-459.
22. Kang W., Wilson M.A., Bender M.A., Glorioso J.C., Wilson S.P. Herpes virus-mediated preproenkephalin gene transfer to the amygdala is antinociceptive. Brain Res. 792:1998;133-135.
23. Kelley A.E., Bless E.P., Swanson C.J. Investigation of the effects of opiate antagonists infused into the nucleus accumbens on feeding and sucrose drinking in rats. J Pharmacol Exp Ther. 278:1996;1499-1507.
24. Konig M., Zimmer A.M., Steiner H., Holmes P.V., Crawley J.N., Brownstein M.J., Zimmer A. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin. Nature (Lond). 383:1996;535-538.
25. Koob G.F., Strecker R.E., Bloom F.E. Effects of naloxone on the anticonflict properties of alcohol and chlordiazepoxide. Subst Alcohol Actions Misuse. 1:1980;447-457.
26. Lopez F., Miller L.G., Thompson M.L., Schatzki A., Chesley S., Greenblatt D.J., Shader R.I. Chronic morphine administration augments benzodiazepine binding and GABA receptor function. Psychopharmacology. 101:1990;545-549.
27. Loughlin S.E., Leslie F.M., Fallon J.H. Endogenous opioid systems. Paxinos G. The Rat Nervous System. 1995;975-1001 Academic Press, Inc, San Diego, CA.
28. McGaugh J.L., Cahill L., Roozendaal B. Involvement of the amygdala in memory storage. Interaction with other brain systems Proc Natl Acad Sci USA. 93:1996;13508-13514.
29. Mester J.C., Pitha P.M., Glorioso J.C. Antiviral activity of herpes simplex virus vectors expressing murine α 1-interferon. Gene Ther. 2:1995;187-196.
30. Millan M.J., Duka T. Anxiolytic properties of opiates and endogenous opioid peptides and their relationship to the actions of benzodiazepines. Mod Probl Pharmacopsychiatry. 17:1981;123-141.
31. Moller C., Wiklund L., Sommer W., Thorsell A., Heilig M. Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Res. 760:1997;94-101.
32. Nowakowska E., Chodera A. Studies on the involvement of opioid mechanism in the locomotor effects of benzodiazepines in rats. Pharm Biochem Behav. 38:1990;265-266.
33. Olson G.A., Olson R.D., Kastin A.J. Endogenous opiates, 1995. Peptides. 17:1996;1421-1466.
34. Paradies M.A., Steward O. Multiple subcellular mRNA distribution patterns in neurons. A nonisotopic in situ hybridization analysis J Neurobiol. 33:1997;473-493.
35. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1997;Academic Press, Inc, San Diego.
36. Pellow S., Chopin P., File S.E., Briley M. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth. 14:1985;149-167.
37. Pesold C., Treit D. The septum and amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res. 638:1994;295-301.
38. Pesold C., Treit D. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res. 671:1995;213-221.
39. Petersen E.N., Braestrup C., Scheel-Kruger J. Evidence that the anticonflict effect of midazolam in the amygdala is mediated by the specific benzodiazepine receptors. Neurosci Lett. 53:1985;285-288.
40. Petrovich G.D., Swanson L.W. Projections from the lateral part of the central amygdalar nucleus to the postulated fear conditioning circuit. Brain Res. 763:1997;247-254.
41. Privette T., Terrian D.M. Kappa opioid agonists produce anxiolytic-like behavior on the elevated plus-maze. Psychopharmacology (Berl). 118:1995;444-450.
42. Richards J.G., Mohler H. Benzodiazepine receptors. Neuropharmacology. 23:1984;233-242.
43. Roberts G.W. Neuropeptides. Cellular morphology, major pathways, and functional considerations Aggleton J.P. The Amygdala. Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction:1992;115-142 Wiley-Liss, Inc, New York.
44. Rocha L., Tatsukawa K., Chugani H.T., Engel J.J., Engel J. Jr. Benzodiazepine receptor binding following chronic treatment with naloxone, morphine and Met-enkephalin in normal rats. Brain Res. 612:1993;247-252.
45. Sanders S.K., Shekhar A. Anxiolytic effects of chlordiazepoxide blocked by injection of GABAA and benzodiazepine receptor antagonists in the region of the anterior basolateral amygdala of rats. Biol Psychiatry. 37:1995;473-476.
46. Scheel-Kruger J., Petersen E.N. Anticonflict effect of the benzodiazpines mediated by a GABAergic mechanism in the amygdala. Eur J Pharmacol. 82:1982;115-116.
47. Spruce B.A., Jackson S., Lowry P.J., Lane D.P., Glover D.M. Monoclonal antibodies to a proenkephalin A fusion peptide synthesized in Escherichia coli recognize novel proenkephalin A precursor forms. J Biol Chem. 263:1988;19788-19795.
48. Tsuda M., Suzuki T., Misawa M., Nagase H. Involvement of the opioid system in the anxiolytic effect of diazepam in mice. Eur J Pharmacol. 307:1996;7-14.
49. Valverde O., Fournie-Zaluski M.C., Roques B.P., Maldonado R. Similar involvement of several brain areas in the antinociception of endogenous and exogenous opioids. Eur J Pharmacol. 312:1996;15-25.
50. Veinante P., Stoeckel M.E., Freund-Mercier M.J. GABA- and peptide-immunoreactivities co-localize in the rat central extended amygdala. NeuroReport. 8:1997;2985-2989.
51. Wuster M., Duka T., Herz A. Diazepam-induced release of opioid activity in the rat brain. Neurosci Lett. 16:1980;335-337.
52. Young W.S., Kuhar M.J. Radiohistochemical localization of benzodiazepine receptors in rat brain. J Pharm Exp Ther. 212:1980;337-346.
53. Zhang H.T., Xu Z.M., Luo Z.P., Qin B.Y. Anxiogenic effect of naltrexone in social interaction test in rats. Chung-KuoYao Li Hsueh Pao - Acta Pharmacologica Sinica. 17:1996;314-317.